A citation-based method for searching scientific literature

Samuel Kohtala, Wiebke Theilmann, Marko Rosenholm, Heidi K Müller, Paula Kiuru, Gregers Wegener, Jari Yli-Kauhaluoma, Tomi Rantamäki. Neuropharmacology 2019
Times Cited: 13







List of co-cited articles
232 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
69

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
61

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
61

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Lace M Riggs, Jaclyn N Highland, Polymnia Georgiou, Edna F R Pereira, Edson X Albuquerque, Craig J Thomas, Carlos A Zarate,[...]. Pharmacol Rev 2018
427
53

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
882
53

Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.
R N Moda-Sava, M H Murdock, P K Parekh, R N Fetcho, B S Huang, T N Huynh, J Witztum, D C Shaver, D L Rosenthal, E J Alway,[...]. Science 2019
257
53

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
46


Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects.
Allison C Nugent, Elizabeth D Ballard, Todd D Gould, Lawrence T Park, Ruin Moaddel, Nancy E Brutsche, Carlos A Zarate. Mol Psychiatry 2019
104
38

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
Sungho Maeng, Carlos A Zarate, Jing Du, Robert J Schloesser, Joseph McCammon, Guang Chen, Husseini K Manji. Biol Psychiatry 2008
847
38

The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.
Chadi G Abdallah, Henk M De Feyter, Lynnette A Averill, Lihong Jiang, Christopher L Averill, Golam M I Chowdhury, Prerana Purohit, Robin A de Graaf, Irina Esterlis, Christoph Juchem,[...]. Neuropsychopharmacology 2018
98
38



Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function.
Eric W Lumsden, Timothy A Troppoli, Scott J Myers, Panos Zanos, Yasco Aracava, Jan Kehr, Jacqueline Lovett, Sukhan Kim, Fu-Hua Wang, Staffan Schmidt,[...]. Proc Natl Acad Sci U S A 2019
79
30

(R)-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2R,6R)-Hydroxynorketamine.
Chun Yang, Youge Qu, Masahito Abe, Dai Nozawa, Shigeyuki Chaki, Kenji Hashimoto. Biol Psychiatry 2017
116
30

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.
C Yang, Y Shirayama, J-c Zhang, Q Ren, W Yao, M Ma, C Dong, K Hashimoto. Transl Psychiatry 2015
340
30

(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions.
Panos Zanos, Jaclyn N Highland, Brent W Stewart, Polymnia Georgiou, Carleigh E Jenne, Jacqueline Lovett, Patrick J Morris, Craig J Thomas, Ruin Moaddel, Carlos A Zarate,[...]. Proc Natl Acad Sci U S A 2019
77
30

(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice.
Jun-Ichi Yamaguchi, Hidetoh Toki, Youge Qu, Chun Yang, Hiroyuki Koike, Kenji Hashimoto, Akiko Mizuno-Yasuhira, Shigeyuki Chaki. Neuropsychopharmacology 2018
63
30

Synaptic dysfunction in depression: potential therapeutic targets.
Ronald S Duman, George K Aghajanian. Science 2012
819
30

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
776
30

Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine.
Kenichi Fukumoto, Manoela V Fogaça, Rong-Jian Liu, Catharine Duman, Taro Kato, Xiao-Yuan Li, Ronald S Duman. Proc Natl Acad Sci U S A 2019
99
30

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
30

Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.
Rong-Jian Liu, Francis S Lee, Xiao-Yuan Li, Francis Bambico, Ronald S Duman, George K Aghajanian. Biol Psychiatry 2012
278
30



Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects.
G M I Chowdhury, J Zhang, M Thomas, M Banasr, X Ma, B Pittman, L Bristow, E Schaeffer, R S Duman, D L Rothman,[...]. Mol Psychiatry 2017
123
30

Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior.
Jason M Dwyer, Jaime G Maldonado-Avilés, Ashley E Lepack, Ralph J DiLeone, Ronald S Duman. Proc Natl Acad Sci U S A 2015
54
30

Acute suppression of spontaneous neurotransmission drives synaptic potentiation.
Elena Nosyreva, Kristen Szabla, Anita E Autry, Alexey G Ryazanov, Lisa M Monteggia, Ege T Kavalali. J Neurosci 2013
180
30

The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome.
H A Sackeim, B Luber, G P Katzman, J R Moeller, J Prudic, D P Devanand, M S Nobler. Arch Gen Psychiatry 1996
133
30

MAPK signaling correlates with the antidepressant effects of ketamine.
Gislaine Z Réus, Flavio Geraldo Vieira, Helena M Abelaira, Monique Michels, Débora B Tomaz, Maria Augusta B dos Santos, Anelise S Carlessi, Morgana V Neotti, Beatriz I Matias, Jaíne R Luz,[...]. J Psychiatr Res 2014
74
30

Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures.
Ashley E Lepack, Eunyoung Bang, Boyoung Lee, Jason M Dwyer, Ronald S Duman. Neuropharmacology 2016
106
30

Cortical Excitability and Activation of TrkB Signaling During Rebound Slow Oscillations Are Critical for Rapid Antidepressant Responses.
Samuel Kohtala, Wiebke Theilmann, Marko Rosenholm, Leena Penna, Gulsum Karabulut, Salla Uusitalo, Kaija Järventausta, Arvi Yli-Hankala, Ipek Yalcin, Nobuaki Matsui,[...]. Mol Neurobiol 2019
22
30

Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.
Wallace C Duncan, Simone Sarasso, Fabio Ferrarelli, Jessica Selter, Brady A Riedner, Nadia S Hejazi, Peixiong Yuan, Nancy Brutsche, Husseini K Manji, Giulio Tononi,[...]. Int J Neuropsychopharmacol 2013
135
30

Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study.
Allison C Nugent, Kathleen E Wills, Jessica R Gilbert, Carlos A Zarate. Psychiatry Res Neuroimaging 2019
21
30

Ketamine metabolite pilot study in a suicidal depression trial.
Michael F Grunebaum, Hanga C Galfalvy, Tse-Hwei Choo, Michelle S Parris, Ainsley K Burke, Raymond F Suckow, Thomas B Cooper, J John Mann. J Psychiatr Res 2019
18
30

Ketamine Treatment and Global Brain Connectivity in Major Depression.
Chadi G Abdallah, Lynnette A Averill, Katherine A Collins, Paul Geha, Jaclyn Schwartz, Christopher Averill, Kaitlin E DeWilde, Edmund Wong, Alan Anticevic, Cheuk Y Tang,[...]. Neuropsychopharmacology 2017
154
30

TMS-induced cortical potentiation during wakefulness locally increases slow wave activity during sleep.
Reto Huber, Steve K Esser, Fabio Ferrarelli, Marcello Massimini, Michael J Peterson, Giulio Tononi. PLoS One 2007
166
30

Sleep recalibrates homeostatic and associative synaptic plasticity in the human cortex.
Marion Kuhn, Elias Wolf, Jonathan G Maier, Florian Mainberger, Bernd Feige, Hanna Schmid, Jan Bürklin, Sarah Maywald, Volker Mall, Nikolai H Jung,[...]. Nat Commun 2016
80
30

Mechanisms of ketamine action as an antidepressant.
P Zanos, T D Gould. Mol Psychiatry 2018
384
30

Circadian regulation of human cortical excitability.
Julien Q M Ly, Giulia Gaggioni, Sarah L Chellappa, Soterios Papachilleos, Alexandre Brzozowski, Chloé Borsu, Mario Rosanova, Simone Sarasso, Benita Middleton, André Luxen,[...]. Nat Commun 2016
93
30


Do the dissociative side effects of ketamine mediate its antidepressant effects?
David A Luckenbaugh, Mark J Niciu, Dawn F Ionescu, Neal M Nolan, Erica M Richards, Nancy E Brutsche, Sara Guevara, Carlos A Zarate. J Affect Disord 2014
166
23

R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.
Ji-Chun Zhang, Su-Xia Li, Kenji Hashimoto. Pharmacol Biochem Behav 2014
202
23

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, Andrew Newberg, Phillip Kronstein, Sami Khalife, William A Kammerer, Zenaide Quezado, David A Luckenbaugh, Giacomo Salvadore,[...]. Arch Gen Psychiatry 2010
673
23

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.
Gerard Sanacora, Michael R Johnson, Arif Khan, Sarah D Atkinson, Robert R Riesenberg, Juan P Schronen, Michael A Burke, John M Zajecka, Luis Barra, Hong-Lin Su,[...]. Neuropsychopharmacology 2017
75
23

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.
Carlos A Zarate, Nancy Brutsche, Gonzalo Laje, David A Luckenbaugh, Swarajya L Vattem Venkata, Anuradha Ramamoorthy, Ruin Moaddel, Irving W Wainer. Biol Psychiatry 2012
191
23

Common Neurotransmission Recruited in (R,S)-Ketamine and (2R,6R)-Hydroxynorketamine-Induced Sustained Antidepressant-like Effects.
Thu Ha Pham, Céline Defaix, Xiaoming Xu, Shi-Xian Deng, Nicolas Fabresse, Jean-Claude Alvarez, Donald W Landry, Rebecca A Brachman, Christine A Denny, Alain M Gardier. Biol Psychiatry 2018
87
23

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
D Jeffrey Newport, Linda L Carpenter, William M McDonald, James B Potash, Mauricio Tohen, Charles B Nemeroff. Am J Psychiatry 2015
362
23

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
Carlos A Zarate, Nancy E Brutsche, Lobna Ibrahim, Jose Franco-Chaves, Nancy Diazgranados, Anibal Cravchik, Jessica Selter, Craig A Marquardt, Victoria Liberty, David A Luckenbaugh. Biol Psychiatry 2012
515
23

Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects.
Brendan D Hare, Ryota Shinohara, Rong Jian Liu, Santosh Pothula, Ralph J DiLeone, Ronald S Duman. Nat Commun 2019
108
23


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.